OA
Oracle Alpha Portfolio holdings
AUM
$55.7M
This Quarter Return
+18.84%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$77.3M
AUM Growth
–
Cap. Flow
+$77.3M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
11.25%
Holding
247
New
247
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Intel
INTC
|
$1.05M |
| 2 |
NVIDIA
NVDA
|
$974K |
| 3 |
GitLab
GTLB
|
$971K |
| 4 |
Samsara
IOT
|
$929K |
| 5 |
Eli Lilly
LLY
|
$909K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 24.76% |
| 2 | Healthcare | 17.27% |
| 3 | Consumer Discretionary | 12.72% |
| 4 | Financials | 10.02% |
| 5 | Energy | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Shenandoah Telecom
SHEN
$720M
| $215K | 0.28% |
+9,926
| New | +$215K |
|
177
World Kinect Corp
WKC
$1.49B
| $213K | 0.28% |
+9,346
| New | +$213K |
|
178
Nike
NKE
$111B
| $212K | 0.27% |
+1,956
| New | +$212K |
|
179
Hershey
HSY
$37.6B
| $212K | 0.27% |
+1,135
| New | +$212K |
|
180
Aramark
ARMK
$10.3B
| $211K | 0.27% |
+7,522
| New | +$211K |
|
181
NextEra Energy, Inc.
NEE
$146B
| $211K | 0.27% |
+3,479
| New | +$211K |
|
182
HCA Healthcare
HCA
$96.3B
| $210K | 0.27% |
+777
| New | +$210K |
|
183
Asana
ASAN
$3.46B
| $209K | 0.27% |
+11,012
| New | +$209K |
|
184
Relay Therapeutics
RLAY
$690M
| $206K | 0.27% |
+18,716
| New | +$206K |
|
185
Nucor
NUE
$33.3B
| $205K | 0.27% |
+1,177
| New | +$205K |
|
186
UnitedHealth
UNH
$281B
| $205K | 0.27% |
+389
| New | +$205K |
|
187
Arcellx
ACLX
$4B
| $204K | 0.26% |
+3,674
| New | +$204K |
|
188
AdaptHealth
AHCO
$1.25B
| $204K | 0.26% |
+27,922
| New | +$204K |
|
189
Celsius Holdings
CELH
$15.7B
| $203K | 0.26% |
+3,728
| New | +$203K |
|
190
Organon & Co
OGN
$2.52B
| $199K | 0.26% |
+13,833
| New | +$199K |
|
191
Medallion Financial
MFIN
$251M
| $199K | 0.26% |
+20,199
| New | +$199K |
|
192
1-800-Flowers.com
FLWS
$329M
| $196K | 0.25% |
+18,210
| New | +$196K |
|
193
Vir Biotechnology
VIR
$714M
| $192K | 0.25% |
+19,062
| New | +$192K |
|
194
Cushman & Wakefield
CWK
$3.67B
| $191K | 0.25% |
+17,650
| New | +$191K |
|
195
NovoCure
NVCR
$1.34B
| $191K | 0.25% |
+12,767
| New | +$191K |
|
196
Entrada Therapeutics
TRDA
$199M
| $189K | 0.24% |
+12,500
| New | +$189K |
|
197
Northeast Community Bancorp
NECB
$287M
| $188K | 0.24% |
+10,623
| New | +$188K |
|
198
Roivant Sciences
ROIV
$8.58B
| $186K | 0.24% |
+16,601
| New | +$186K |
|
199
Amplitude
AMPL
$1.44B
| $181K | 0.23% |
+14,200
| New | +$181K |
|
200
Nurix Therapeutics
NRIX
$697M
| $180K | 0.23% |
+17,434
| New | +$180K |
|